Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.260
+0.020 (0.47%)
Apr 7, 2026, 4:00 PM EDT - Market closed
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $249.3 million as of April 8, 2026. Its market cap has increased by 50.76% in one year.
Market Cap
249.30M
Enterprise Value
158.74M
1-Year Change
50.76%
Ranking
Category
Stock Price
$4.26
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $249.30M, an increase of 26.26%. That is a compound annual growth rate of 4.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 248.13M | 5.89% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alector | 265.97M |
| Adagene | 263.63M |
| Editas Medicine | 261.32M |
| Cellectis | 260.21M |
| Sol-Gel Technologies | 259.75M |
| Coherus Oncology | 259.31M |
| ALX Oncology Holdings | 259.27M |
| Cybin | 256.18M |